| 1 |
Pitfalls in clinical trials reveal need for well tolerated, more effective depigmenting agents |
|
|
| S. Saxena,R. M. Andersen,H. I. Maibach |
|
| Journal of Dermatological Treatment. 2015; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Rationale of using hypopigmenting drugs and their clinical application in melasma |
|
|
| Kabir Sardana,Sneha Ghunawat |
|
| Expert Review of Clinical Pharmacology. 2015; 8(1): 123 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Current clinical use of depigmenting agents |
|
|
| Jung Won Shin,Kyoung Chan Park |
|
| Dermatologica Sinica. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Evidence-Based Treatment for Melasma: Expert Opinion and a Review |
|
|
| Krupa Shankar,Kiran Godse,Sanjeev Aurangabadkar,Koushik Lahiri,Venkat Mysore,Anil Ganjoo,Maya Vedamurty,Malavika Kohli,Jaishree Sharad,Ganesh Kadhe,Pashmina Ahirrao,Varsha Narayanan,Salman Abdulrehman Motlekar |
|
| Dermatology and Therapy. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Betulinic acid isolated from Vitis amurensis root inhibits 3-isobutyl-1-methylxanthine induced melanogenesis via the regulation of MEK/ERK and PI3K/Akt pathways in B16F10 cells |
|
|
| Kyong-Suk Jin,You Na Oh,Sook Kyung Hyun,Hyun Ju Kwon,Byung Woo Kim |
|
| Food and Chemical Toxicology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Catalysis and inactivation of tyrosinase in its action on hydroxyhydroquinone |
|
|
| Maria del Mar Garcia-Molina,Jose Luis Muñoz-Muñoz,Jose Berna,Pedro Antonio García-Ruiz,Jose Neptuno Rodriguez-Lopez,Francisco Garcia-Canovas |
|
| IUBMB Life. 2014; 66(2): 122 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Action of tyrosinase on hydroquinone in the presence of catalytic amounts of o-diphenol. A kinetic study |
|
|
| Maria del Mar Garcia-Molina,Jose Berna,Jose Luis Muñoz-Muñoz,Pedro Antonio García-Ruiz,Manuela Garcia Moreno,José Rodriguez Martinez,Francisco Garcia-Canovas |
|
| Reaction Kinetics, Mechanisms and Catalysis. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
